As a country partner at Bio Asia, we're bringing a holistic representation of the Swiss healthtech ecosystem spanning from corporates to startups to academia to investors. We're eager to collaborate with the key players in India and pursue new solutions today, for tomorrow.
Unspalsh/ Headway

Swiss delegation at BioAsia 2020


There’s huge potential for Switzerland and India to co-create solutions for tomorrow. That’s why we’re bringing the best-in-class industry experts to BioAsia 2020…


Startups

Dr. Jan Stapelfeldt

Perivision.io

PeriVision’s goal is to help prevent blindness caused by glaucoma. Worldwide roughly 80 million people are affected by this incurable eye disease. Early detection and continuous monitoring is key to prevent people from getting blind. Perivision strives to create eye care that is affordable and accessible for everyone by leveraging Virtual Reality technology into daily clinical practice. PeriVision created visual field testing using virtual reality technology. PeriVision’s patent-pending deep learning algorithms drastically cut down examination times.

Perivision is here to: explore collaborations, discover market engagement models for perivison’s product. Also, to represent the dynamic Innovation center from teh University of Bern, ARTORG.

Dr. Rajwinder lehal

Cellastia AG

Cellestia, spun off from EPFL and founded in 2014, is ranked 19 among the top 100 swiss startups. Cellestia is a privately-owned clinical-stage biopharma company led by an experienced team of scientists, drug developers and business professionals. Celleastia’s drug discovery platform, built on a unique mode of action and together with companion diagnostics, is a first-in-class solution for orphan cancers such as cancer of the salivary gland and childhood Leukaemia.

Cellestia is here to explore the thriving Chemsitry/ Biology Contract research services to develop the product pipeline, and understand the market dynamics and potential investments.

Dr. Tino Topper

Bott Medical

Bottmedical AG is a Swiss deep-tech spin-off from the University of Basel based on an IP portfolio related to the core polymer thin-film technology. Their core products include a natural bio-based materilal for dental alignment and a unique ultra-thin nanosensor technology as a tactile interface between the tongue and a smartphone app for interactive myofunctional training of the tongue as a cure for sleep apnea.

Bott Medical looks at evaluating the indian market to understand the APAC dental/orthodontic business potential in terms of customer values, commercial potential and potential scale-up opportunities for bio-based polymer technologies.

Dr. Hans-Peter beck and Mr. Chang Yun

Noul

Noul’s innovative malaria diagnostic solution is a unique all-in-one and point-of-care platform enabling to automatically perform (i) sample preparation (ii) high resolution digital imaging, (iii) embedded artificial intelligence (AI) analysis, and (iv) efficient surveillance system via 3G/LTE system for real-time data tracking and geo-spatial mapping. The device is designed to replace manual microscopic examincation to the fully automated one, significantly reducing cost of personnel and lab equipments but providing much more consistent results than classical microscopy.

Noul is here to understand malarial prevalence in India; to meet with potential buyers in hospitals, research centres, etc. and to assess business opportunities with potential distributors.


Innovation Centers

Mr. Christain Elias Schenider

University of basel Innovation center

Christian is the Head of Innovation and Entrepreneurship, University of Basel Innovation center, leads initiatives to support entrepreneurship, Internationalization and PPP initiatives.

Christian is here to engage with India’s Innovation centres for Scientific and Social Innovation; leading a delegation of startups, mentors and specilaists from the the Innovation centre; showcasing the Basel Innovation network.

Dr. Hans-Florian Zeilhofer

University of Basel Innovation Center

Associate Vice president Innovation, University of Basel, Dr. Zeilhofer is Professor at the Department of Biomedical Engineering and Chief Physician for Cranio-Maxillofacial Surgery at the University Hospital Basel and a serial entrepreneur.


Universities

Dr. Margrit Leuthold

Deputy Director – Future Health Technologies Program, Singapore-ETH Center

Dr. Margrit Leuthold is in charge of the strategic positioning of medical research at ETH Zurich. Before joining ETH again, she was CEO of the foundation ‘Patient Safety Switzerland’, CEO of swissnex India (Bangalore, India), head of ETH Global, and Secretary General at the Swiss Academy of Medical Sciences. She started her career in science administration at the Swiss National Science Foundation and as staff member of the President at ETH. On a honorary level, she is founding president of Synapsis Foundation, a foundation supporting Alzheimer’s research.

Dr. Indraneel Ghose

Sr. Thematic Advisor – Embassy of Switzerland in New Delhi

India anchor for the University of Geneva to build their strategic partnerships with companies and private institution.


Cantonal Representatives

Anke Hollnagel

Director Asia, BaselArea Swiss, Greater Basel area

Anke was previously Head of Marketing and Sales at Doetsch Grether Ltd., a medium-sized Swiss pharmaceutical company. She also worked as a Senior Brand Manager for Colgate-Palmolive Ltd. and Consultant for Boston Consulting Group. Anke represnts the Basel Area Swss Investsment Council.

Mr. Amitabh Arora

Director Key Accounts, Greater Geneva Bern Area

Amitabh is currently working as Director Key Accounts at the Greater Geneva Berne area (GGBa), the economic development agency of western Switzerland. GGBa offers a comprehensive range of services at no charge to foreign companies seeking to establish a presence in Switzerland.

Misha Bajaj

Manager International Tax Services, PwC Switzerland

Misha is an Economic Development & Marcom Specialist. She has an extensive experience of trade & investment promotion across a range of verticals like energy, automotive, aerospace, infrastructure, railways, environment & water, life sciences, food & drink, education and technology.

Ms. Misha represents the St. Gallen-Bodensee area.


Investment Advisors

Tino Gaberthüel

Partner, Lenz & Staehelin

Investment legal advisor

Tino is a Corporate Law attorney in Zürich, Switzerland. He regularly advises corporates and individuals on all matters of Swiss business law and is specialized in domestic and cross-border mergers & acquisitions (M&A), including public tender offers, private equity transactions as well as securities and capital markets law.

Christoph Pauli

Director International Tax, PwC Switzerland

Investment legal advisor

Christoph is the Tax Director at PwC for more than 20 years.

Kay Egger

Manager International Tax Services, PwC Switzerland

Investment Tax Advisor

Mr. kay Egger has experinece with Advising on national and multinational corporate and individual clients. Experienced and involved in all sorts of tax linked matters, such as: Corporate and individual tax compliance and consulting services, employee and self-employed related taxes, inheritance tax, relocation services, national and international corporate tax structuring and reorganisations, negotiation with the tax authorities as well as tax litigation cases.

Anand Pazhenkottil

Attorney at Law – Partner – Blue Lake Legal

Anand is Attorney at Law and is one of the founding partners of Blue Lake Legal in Switzerland. He advises companies as well as individuals on complex immigration issues. His focus is on corporate immigration to Switzerland as well as refugee and asylum law.

Tarun Gupta

Co-Founder & CEO, T&A Consulting

Foreign trade Expert

Arun is active in the cross-border space specifically in carving market entry strategy, building distribution channels or carrying out diagnostics of market penetration. He has close working relationships at the CXO level in leading Indian organizations and various Foreign Economic Development Organization’s looking to strengthen trade and investment ties with India.

Sarojini Vasant

Investment Promotion Advisor – Swiss Business Hub, India


Innovation Partners

Dr. Philipp Marchand

Vossius and Partner

Dr. Marchand is an IP Specialist focusing on the Life sciences segment in Europe and Switzerland in IP and portfolio management at Vossius and Partner. Dr. Marchand, as part of the UniBas Innovation center delegation, is in India to understand, explore and engage with the Indian Pharma and Biotech industry.

Mr. Ulrich Hoffmann

University of Basel Innovation center

Mr. Hoffman is the Ex-head of Group operations, UBS. He currently mentors startups at the University of Basel and is also on the Board of Directors and Strategy of the AI Business School.

Mr. Hoffmann is looking to explore and engage with the Indian Pharma and Biotech industry, as well as to represent the AI business school.


SDC

Marylaure Crettaz Corredo

Head of Swiss Agency for Development and Cooperation in India

Marylaure Crettaz has more than 20 years of international cooperation experience, starting with 4 years in the humanitarian field. In 2003, she joined the Swiss development cooperation and has since then consolidated her experience in natural resources management and governance, rural development, agriculture and food security, economic development and more recently climate change, energy and low-carbon development.

The Swiss Agency for Development and Cooperation (SDC) recently launched a new programme to improve the health and environment of populations exposed to water pollution by industrial activities. The programme supports industries, including supply chains of multinational companies, in understanding and addressing pollution-related risks. One of the target industries of the programme are manufacturers of antibiotics in India. Through a smart mix of partners and initiatives, SDC intends to shape the global dialogue on water pollution through strategic partnerships with global alliances, such as the AMR Industry Alliance targeting local industries and suppliers along the supply chain of antibiotic production in India.